Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CAPECITABINE Cause Hepatic function abnormal? 476 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 476 reports of Hepatic function abnormal have been filed in association with CAPECITABINE (Capecitabine). This represents 0.8% of all adverse event reports for CAPECITABINE.

476
Reports of Hepatic function abnormal with CAPECITABINE
0.8%
of all CAPECITABINE reports
39
Deaths
134
Hospitalizations

How Dangerous Is Hepatic function abnormal From CAPECITABINE?

Of the 476 reports, 39 (8.2%) resulted in death, 134 (28.2%) required hospitalization, and 19 (4.0%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CAPECITABINE. However, 476 reports have been filed with the FAERS database.

What Other Side Effects Does CAPECITABINE Cause?

Diarrhoea (9,277) Nausea (6,248) Palmar-plantar erythrodysaesthesia syndrome (5,294) Fatigue (5,018) Death (4,422) Vomiting (4,111) Disease progression (3,808) Off label use (3,193) Malignant neoplasm progression (2,425) Asthenia (2,352)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Which CAPECITABINE Alternatives Have Lower Hepatic function abnormal Risk?

CAPECITABINE vs CAPIVASERTIB CAPECITABINE vs CAPLACIZUMAB CAPECITABINE vs CAPLACIZUMAB-YHDP CAPECITABINE vs CAPMATINIB CAPECITABINE vs CAPREOMYCIN

Related Pages

CAPECITABINE Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal CAPECITABINE Demographics